Rchr
J-GLOBAL ID:201801017161939364   Update date: Mar. 29, 2021

TOMIZUKA KAZUMA

トミヅカ カズマ | TOMIZUKA KAZUMA
Affiliation and department:
Research field  (1): Applied molecular and cellular biology
Papers (37):
  • Isoda Y, Piao W, Taguchi E, Iwano J, Takaoka S, Uchida A, Yoshikawa K, Enokizono J, Arakawa E, Tomizuka K, et al. Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo. Oncotarget. 2018. 9. 59. 31422-31431
  • Eiko Hayase, Daigo Hashimoto, Kiminori Nakamura, Clara Noizat, Reiki Ogasawara, Shuichiro Takahashi, Hiroyuki Ohigashi, Yuki Yokoi, Rina Sugimoto, Satomi Matsuoka, et al. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. JOURNAL OF EXPERIMENTAL MEDICINE. 2017. 214. 12. 3507-3518
  • Daisuke Shinmi, Ryosuke Nakano, Keisuke Mitamura, Minami Suzuki-Imaizumi, Junko Iwano, Yuya Isoda, Junichi Enokizono, Yasuhisa Shiraishi, Emi Arakawa, Kazuma Tomizuka, et al. Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen. CANCER MEDICINE. 2017. 6. 4. 798-808
  • Takahashi N, Niwa R, Nakano R, Tomizuka K. [Strategy for technology development of antibody therapeutics]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2016. 147. 4. 235-240
  • Kengo Yamawaki, Yuichiro Kondo, Tsutomu Okada, Takeshi Oshima, Makoto Kakitani, Kazuma Tomizuka. The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders. SCIENTIFIC REPORTS. 2016. 6. 18849
more...
MISC (28):
  • Hisashi Hasegawa, Kengo Yamawaki, Takuya Murakami, Kenji Nagao, Makoto Kakitani, Kazuma Tomizuka. Anabolic bone effects of soluble Frizzled1, 2 and 7 receptors in mice. JOURNAL OF BONE AND MINERAL RESEARCH. 2017. 32. S73-S74
  • Natsuko Fujita, Kenji Oritani, Michiko Ichii, Norimitsu Saitoh, Kengo Yamawaki, Kazuma Tomizuka, Yuzuru Kanakura. Osteoblast Stimulating Factor-5 Regulates B Lymphopoiesis Via Inhibiting Pre B Cell Proliferation. BLOOD. 2014. 124. 21
  • Takafumi Yokota, Kenji Oritani, Takao Sudo, Tomohiko Ishibashi, Yukiko Doi, Yoko Habuchi, Michiko Ichii, Daisuke Okuzaki, Kazuma Tomizuka, Kengo Yamawaki, et al. SFRP5 Inhibits Early Stages Of B-Cell Differentiation and Modulates Estrogen-Related Changes In The Immune System. BLOOD. 2013. 122. 21
  • M. Kakeda, K. Nagata, H. Matsuno, M. Hiratsuka, A. Sano, S. Nishikawa, M. Osaki, Y. Kazuki, M. Oshimura, K. Tomizuka. A New Chromosome 14-based Human Artificial Chromosome (HAC) Vector System for Efficient Transgene Expression in Human Primary Cells. EUROPEAN JOURNAL OF CANCER. 2012. 48. S152-S152
  • S. Takashima, M. Kadowaki, K. Aoyama, M. Koyama, T. Oshima, K. Tomizuka, K. Akashi, T. Teshima. STIMULATION OF INTESTINAL STEM CELLS WITH R-SPONDIN1 REGULATES SYSTEMIC GRAFT-VERSUS-HOST DISEASE. EXPERIMENTAL HEMATOLOGY. 2010. 38. 9. S35-S36
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page